journal article·2010-03-15Open access

Dendritic cell responses to self‐assembled monolayers of defined chemistries

Sucharita P. Shankar, Timothy A. Petrie, Andrés J. García, Julia E. Babensee

Abstract

Abstract Biomaterial contact triggers dendritic cell (DC) maturation, to an extent depending on the biomaterial, ultimately enhancing an immune response toward associated antigens, implying a role for biomaterials as adjuvants. Self‐assembled monolayers (SAM) of alkanethiols on titanium/gold‐coated surfaces presenting different chemistries were used to study effects of biomaterial surface chemistry on DC maturation. Although DCs treated with OH, COOH, or NH2SAMs showed modest maturation, those treated with CH3SAMs were least mature, all based on cytospins, allostimulatory capacity, or maturation marker expression. Surprisingly, DCs treated with CH3SAMs secreted highest levels of proinflammatory tumor necrosis factor‐α (TNF‐α) or interleukin‐6 (IL‐6) but were least mature. Secretion of anti‐inflammatory mediators by DCs treated with CH3SAMs was not responsible for mitigating DC maturation under these conditions. Interestingly, elevated levels of apoptotic markers were measured associated with DCs and T cells upon CH3SAMs contact. Since phagocytosis of apoptotic DCs has strong immunosuppressive effects on DCs, more apoptotic DCs on CH3SAMs may account for lower DC maturation. Finally, higher expression of cytotoxic T lymphocyte associated antigen receptor‐4 (CTLA‐4) on T cells may imply a mechanism of T cell inhibition on CH3SAMs. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res 2010
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (87)

Show source-provided references
1. 10.1126/science.849352910.1126/science.8493529 ↗
2. 10.1089/15491680432310505310.1089/154916804323105053 ↗
3. 10.1016/j.trim.2003.12.00510.1016/j.trim.2003.12.005 ↗
4. 10.1007/s00253-004-1580-z10.1007/s00253-004-1580-z ↗
5. 10.1097/00002480-198804000-0000510.1097/00002480-198804000-00005 ↗
6. Immune considerations in tissue engineering10.1016/S0094-1298(20)32656-0 ↗
7. 10.1038/nbt105510.1038/nbt1055 ↗
8. 10.1089/ten.tea.2007.026410.1089/ten.tea.2007.0264 ↗
9. 10.1016/j.biomaterials.2007.08.02010.1016/j.biomaterials.2007.08.020 ↗
10. 10.1016/S0169-409X(98)00023-410.1016/S0169-409X(98)00023-4 ↗
11. 10.1038/1505810.1038/15058 ↗
12. 10.1038/3258810.1038/32588 ↗
13. 10.1084/jem.184.3.92310.1084/jem.184.3.923 ↗
14. 10.1038/9060910.1038/90609 ↗
15. 10.1038/3509262010.1038/35092620 ↗
16. 10.1038/3510052910.1038/35100529 ↗
17. 10.1146/annurev.immunol.20.083001.08435910.1146/annurev.immunol.20.083001.084359 ↗
18. 10.1038/3502122810.1038/35021228 ↗
19. 10.1006/smim.1998.014210.1006/smim.1998.0142 ↗
20. 10.1172/JCI1183710.1172/JCI11837 ↗
21. 10.1002/jbm.a.3042910.1002/jbm.a.30429 ↗
22. 10.1016/0264-410X(96)00005-910.1016/0264-410X(96)00005-9 ↗
23. Modulation of the immune response to tetanus toxoid by polylactide‐polyglycolide microspheres
24. 10.1080/0265204011005526110.1080/02652040110055261 ↗
25. 10.1016/S0142-9612(03)00531-310.1016/S0142-9612(03)00531-3 ↗
26. 10.1016/j.biomaterials.2004.08.02310.1016/j.biomaterials.2004.08.023 ↗
27. 10.1002/jbm.a.3013110.1002/jbm.a.30131 ↗
28. 10.1002/jbm.a.3079810.1002/jbm.a.30798 ↗
29. 10.1073/pnas.93.20.1077510.1073/pnas.93.20.10775 ↗
30. 10.1021/ja970819l10.1021/ja970819l ↗
31. 10.1021/la000465310.1021/la0004653 ↗
32. 10.1021/jp972635z10.1021/jp972635z ↗
33. 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H ↗
34. 10.1021/la026716k10.1021/la026716k ↗
35. 10.1016/S0142-9612(97)00029-X10.1016/S0142-9612(97)00029-X ↗
36. 10.1002/jbm.82029041410.1002/jbm.820290414 ↗
37. 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-110.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1 ↗
38. 10.1016/S0142-9612(99)00115-510.1016/S0142-9612(99)00115-5 ↗
39. 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E ↗
40. 10.1002/jbm.a.3016510.1002/jbm.a.30165 ↗
41. 10.1016/j.biomaterials.2005.04.04210.1016/j.biomaterials.2005.04.042 ↗
42. 10.1016/j.biomaterials.2003.09.04710.1016/j.biomaterials.2003.09.047 ↗
43. 10.1002/jemt.2014110.1002/jemt.20141 ↗
44. 10.1002/jbm.a.3060210.1002/jbm.a.30602 ↗
45. 10.1002/jbm.a.1053710.1002/jbm.a.10537 ↗
46. 10.1021/la034810a10.1021/la034810a ↗
47. 10.1038/nri72310.1038/nri723 ↗
48. 10.1016/S0092-8674(00)80693-510.1016/S0092-8674(00)80693-5 ↗
49. 10.1038/nri118210.1038/nri1182 ↗
50. 10.1016/0022-1759(96)00078-610.1016/0022-1759(96)00078-6 ↗
51. 10.1084/jem.179.4.110910.1084/jem.179.4.1109 ↗
52. 10.1146/annurev.immunol.18.1.76710.1146/annurev.immunol.18.1.767 ↗
53. 10.1093/intimm/dxg09910.1093/intimm/dxg099 ↗
54. 10.1681/ASN.200505052310.1681/ASN.2005050523 ↗
55. 10.1097/01.mjt.0000178766.60234.e210.1097/01.mjt.0000178766.60234.e2 ↗
56. 10.1126/science.112254510.1126/science.1122545 ↗
57. 10.1007/3-540-27320-4_1210.1007/3-540-27320-4_12 ↗
58. 10.3121/cmr.3.3.16610.3121/cmr.3.3.166 ↗
59. 10.1046/j.1365-2249.2003.02202.x10.1046/j.1365-2249.2003.02202.x ↗
60. 10.4049/jimmunol.168.11.558910.4049/jimmunol.168.11.5589 ↗
61. 10.1002/art.1113010.1002/art.11130 ↗
62. 10.1042/cs104002710.1042/cs1040027 ↗
63. 10.1067/mlc.2002.12126010.1067/mlc.2002.121260 ↗
64. CTLA‐4 regulates tolerance induction and T cell differentiation in vivo10.4049/jimmunol.160.8.3855 ↗
65. 10.1016/S0952-7915(99)80047-810.1016/S0952-7915(99)80047-8 ↗
66. 10.1182/blood-2005-10-407710.1182/blood-2005-10-4077 ↗
67. 10.1016/S0198-8859(00)00240-810.1016/S0198-8859(00)00240-8 ↗
68. 10.1038/nri202010.1038/nri2020 ↗
69. 10.1073/pnas.040218310110.1073/pnas.0402183101 ↗
70. 10.4049/jimmunol.175.1.1510.4049/jimmunol.175.1.15 ↗
71. 10.4049/jimmunol.167.5.254710.4049/jimmunol.167.5.2547 ↗
72. 10.1111/j.0300-9475.2004.01354.x10.1111/j.0300-9475.2004.01354.x ↗
73. 10.1189/jlb.120575510.1189/jlb.1205755 ↗
74. 10.1182/blood-2005-12-481210.1182/blood-2005-12-4812 ↗
75. 10.1038/375151a010.1038/375151a0 ↗
76. 10.1038/nbt133210.1038/nbt1332 ↗
77. 10.1016/j.vaccine.2003.09.04410.1016/j.vaccine.2003.09.044 ↗
78. 10.1189/jlb.090454110.1189/jlb.0904541 ↗
79. 10.1038/nmat173710.1038/nmat1737 ↗
80. 10.1002/jbm.a.3031610.1002/jbm.a.30316 ↗
81. 10.1002/jbm.a.3198110.1002/jbm.a.31981 ↗
82. 10.1002/jbm.a.1048810.1002/jbm.a.10488 ↗
83. 10.1016/j.biomaterials.2004.09.00210.1016/j.biomaterials.2004.09.002 ↗
84. 10.1083/jcb.151.6.130510.1083/jcb.151.6.1305 ↗
85. 10.1084/jem.2002026310.1084/jem.20020263 ↗
86. 10.1016/S1074-7613(00)80278-210.1016/S1074-7613(00)80278-2 ↗
87. Profiles of carbohydrate ligands associated with adsorbed proteins on self‐assembled monolayers of defined chemistries10.1002/jbm.a.32457 ↗